Preliminary reports reveal conolidine may perhaps inhibit distinct ion channels, cutting down neuronal excitability and limiting pain indicators. This mechanism is particularly relevant in neuropathic ache, exactly where abnormal signaling leads to persistent distress. Moreover, conolidine appears to affect G protein-coupled receptor (GPCR) pathway